Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Phase of Trial: Phase III
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Idalopirdine (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Registrational; Therapeutic Use
- Acronyms STARSHINE
- Sponsors Lundbeck A/S
- 23 Sep 2016 Status changed from active, no longer recruiting to completed.
- 22 Sep 2016 Results published in a Lundbeck media release.
- 22 Sep 2016 Primary endpoint has not been met. (Change in cognition), according to a Lundbeck media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History